Literature DB >> 3814679

Conditioning and the delayed onset of a haloperidol-induced behavioral effect.

R J Carey.   

Abstract

In a series of experiments, rats were given daily injections of 0.3 mg/kg haloperidol or vehicle 1 hr prior to behavioral testing. In these experiments, when rats were placed in an illuminated compartment and given the opportunity to enter a darkened compartment, haloperidol- and vehicle-treated rats initially entered the dark compartment with similar latencies. With repeated treatments, however, the haloperidol group gradually took increasingly longer times to enter the dark compartment. Furthermore, when the drug treatments of the groups were reversed, behavioral performance was dissociated from the drug state of the animal. Vehicle rats switched to haloperidol entered the dark compartment much more rapidly than haloperidol rats switched to vehicle. As additional control procedures, rats were given haloperidol 1 hr posttrial or were given haloperidol and only placed in the dark compartment. These haloperidol treatments did not differ from vehicle treatments. The gradual development of long latencies to initiate behavior and the persistence of this behavior during withdrawal from the haloperidol are consistent with the establishment of a conditioned drug response. This observation suggests that conditioning may contribute to the delayed onset of response in the clinical use of neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3814679     DOI: 10.1016/0006-3223(87)90145-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  1 in total

1.  Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats.

Authors:  Taygun C Uzuneser; Eva-Maria Weiss; Jana Dahlmanns; Liubov S Kalinichenko; Davide Amato; Johannes Kornhuber; Christian Alzheimer; Jan Hellmann; Jonas Kaindl; Harald Hübner; Stefan Löber; Peter Gmeiner; Teja W Grömer; Christian P Müller
Journal:  J Psychopharmacol       Date:  2020-12-04       Impact factor: 4.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.